<img src="https://trc.taboola.com/1321591/log/3/unip?en=page_view" width="0" height="0" style="display:none">
Fact Check Library

Fact Check with Logically.

Download the Free App Today

true
true

CLAIM ID

f70e6b63

The Reserve Bank of India cut the repo rate by 40 basis points to 4 percent from 4.40 percent and reverse repo to 3.35 percent from 3.75 percent.

RBI in a press release confirms a reduction in the repo rate to revive growth and mitigate the impact of COVID-19 on the economy.

RBI in a press release confirms a reduction in the repo rate to revive growth and mitigate the impact of COVID-19 on the economy.The Reserve Bank of India(RBI) on May 22, 2020, has announced its decision to reduce the policy repo rate by 40 basis points to 4.0 percent from 4.40 percent with immediate effect. These reductions in the repo rates by the RBI is undertaken for a second time in the year 2020 after an off-cycle policy review to counter the economic fallout from an ongoing nationwide lockdown to contain the spread of the COVID-19 disease. The reverse repo rate under the liquidity adjustment facility(LAF) stands reduced to 3.35 percent from 3.75 percent.

The Monetary Policy Statement(MPC) also decided to proceed with the accommodative stance as long as it is important to revive growth and mitigate the impact of COVID-19 on the economy while ensuring that inflation remains within the target.

The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention, and available treatment, please refer to the World Health Organisation or your national healthcare authority.

Have a question or correction on one of our fact-checks?

If you think a claim has been misjudged or requires correction, please send us evidence to support your error claim. We will revisit our evidence and verdict and conduct additional research to verify new information.

Fact Check of the Day

misleading

397 children were diagnosed with heart inflammation after receiving Pfizer’s COVID-19 vaccine in U.S.